Abstract:BACKGROUND/AIMS:The long non-coding RNA colorectal neoplasia differentially expressed (CRNDE) contributes to the proliferation and migration of tumors. However, its molecular mechanism underlying gastric cancer remains unknown. In the present study, we investigated whether CRNDE was involved in the development of colorectal cancer via the binding of microRNA (miR)-217 with transcription factor 7-like 2 (TCF7L2) to enhance the Wnt signaling pathway.METHODS:Quantitative polymerase chain reaction was used to detect CRNDE, miR-217 and TCF7L2 in colorectal cancer tissues and cells. The CCK-8 assay, wound healing assay, and Transwell assay were used to detect cell proliferation, migration and invasion, respectively. Western blotting and luciferase activity assays were used to identify CRNDE and TCF7L2 as one of the direct targets of miR-217. The activity of the Wnt/β-catenin signaling pathway was analyzed by the TOPflash assay, and the subcellular localization of β-catenin and TCF7L2 was analyzed by western blotting and confocal microscopy.RESULTS:In this study, we found that high expression of CRNDE is negatively correlated with low expression of miR-217 in colorectal cancer tissue and colorectal cancer cells. The dual luciferase reporter analysis showed that miR-217 is bound to CRNDE and TCF7L2 and negatively regulate their expression. CRNDE down-regulation inhibited the cell proliferation, migration and invasion in vitro and in vivo and the inhibitions were both completely blocked after miR-217 inhibition or TCF7L2 overexpression. Finally, TOPflash analysis showed that the activity of Wnt/β-catenin signaling is inhibited by CRNDE down-regulation and rescued by TCF7L2 over-expression. Consistently immunostaining and western blotting analysis showed that the expression of b-catenin and TCF7L2 in the nucleus was significantly decreased by CRNDE down-regulation and was rescued by TCF7L2 over-expression.CONCLUSIONS:The present study suggest that CRNDE involves in the cell proliferation, migration and invasion of colorectal cancer cells via increasing the expression of TCF7L2 and activity of Wnt/β-catenin signaling through binding miR-217 competitively.

Long noncoding RNA CRNDE promotes colorectal cancer cell proliferation via epigenetically silencing DUSP5/CDKN1A expression

SP1-induced Lncrna TINCR Overexpression Contributes to Colorectal Cancer Progression by Sponging Mir-7-5p

Long noncoding RNA CRNDE stabilized by hnRNPUL2 accelerates cell proliferation and migration in colorectal carcinoma via activating Ras/MAPK signaling pathways

The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling

Increased Expression of the Long Noncoding RNA CRNDE-h Indicates a Poor Prognosis in Colorectal Cancer, and is Positively Correlated with IRX5 Mrna Expression

The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding Mir-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.

Highly expressed long non-coding RNA CRNDE promotes cell proliferation through PI3K/AKT signalling in non-small cell lung carcinoma.

Long Non-Coding RNA CRNDE Enhances Cervical Cancer Progression by Suppressing PUMA Expression

Highly Expressed Lncrna CRNDE Promotes Cell Proliferation Through Wnt/β-catenin Signaling in Renal Cell Carcinoma

LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinoma.

A New Light on Potential Therapeutic Targets for Colorectal Cancer Treatment

Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression

Long Non-Coding RNA CRNDE Promotes Malignant Progression of Hepatocellular Carcinoma Through the Mir-33A-5p/cdk6 Axis

CRNDE: A Valuable Long Noncoding RNA for Diagnosis and Therapy of Solid and Hematological Malignancies

Long Noncoding RNA HULC Promotes Colorectal Carcinoma Progression Through Epigenetically Repressing NKD2 Expression

Long Noncoding RNA CRNDE Promotes Multiple Myeloma Cell Growth by Suppressing Mir-451.

Long non-coding RNA SNHG17 is an unfavourable prognostic factor and promotes cell proliferation by epigenetically silencing P57 in colorectal cancer.

LncRNA CRNDE Drives the Progression of Hepatocellular Carcinoma by inducing the Immunosuppressive Niche

Overexpression of CRNDE promotes the progression of bladder cancer

LncRNA CRNDE is Activated by SP1 and Promotes Osteosarcoma Proliferation, Invasion, and Epithelial‐mesenchymal Transition Via Wnt/β‐catenin Signaling Pathway

Upregulation of Long Non-Coding Rna Prncr1 in Colorectal Cancer Promotes Cell Proliferation and Cell Cycle Progression